A significant number of well-differentiated thyroid cancers progress or recur, becoming
resistant to current therapeutic options. Mouse models recapitulating the genetic and …

The overall prognosis of thyroid cancer is excellent, but some patients have grossly invasive
disease and distant metastases with limited responses to systemic therapies. Thus, relevant …

Thyroid cancer is the most common endocrine neoplasm, and its rate is rising at an alarming
pace. Thus, there is a compelling need to develop in vivo models which will not only enable …

Simple Summary Advancements in thyroid cancer are dependent on the availability of
experimental models allowing for investigation in the laboratory setting. Here, we detail the …

Although the overall prognosis of differentiated thyroid cancer (DTC), the most common
endocrine malignancy, is favorable, a subset of patients exhibits aggressive features …

The prognosis from thyroid cancer subtypes in humans covers a spectrum from “cured at
almost 90%” to “100% lethal.” Invasive and poorly differentiated forms of thyroid cancer are …

Thyroid carcinomas, the most common endocrine tumors in humans, have an increasing
incidence in the US and worldwide. There are four major types of thyroid cancers: papillary …

Thyroid cancer is the most common endocrine malignancy and the incidence is rising.
Currently, there are no effective treatments for patients with advanced forms of thyroid …

Simple Summary Laboratory experimental models are essential for advancements in thyroid
cancer translational research. In this study, we discuss the development and …

Background: Thyroid cancer is the most common endocrine tumor and is increasing in
incidence. The aim of this study was to review mouse models of differentiated thyroid cancer …